Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Receivables (2016 - 2026)

Eastman Chemical (EMN) has disclosed Receivables for 18 consecutive years, with $1.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Receivables fell 3.34% year-over-year to $1.2 billion; the TTM value through Mar 2026 reached $1.2 billion, down 3.34%, while the annual FY2025 figure was $999.0 million, 13.14% up from the prior year.
  • Receivables hit $1.2 billion in Q1 2026 for Eastman Chemical, up from $999.0 million in the prior quarter.
  • Across five years, Receivables topped out at $1.6 billion in Q1 2022 and bottomed at $883.0 million in Q4 2024.
  • Average Receivables over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
  • Year-over-year, Receivables dropped 27.92% in 2023 and then rose 15.93% in 2024.
  • Eastman Chemical's Receivables stood at $1.3 billion in 2022, then decreased by 9.63% to $1.2 billion in 2023, then dropped by 23.48% to $883.0 million in 2024, then grew by 13.14% to $999.0 million in 2025, then grew by 21.82% to $1.2 billion in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $1.2 billion, $999.0 million, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.